Ask Sterling

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving the EV sector growth?

Companies Sectors Ask Sterling Compare

Favorites

Revenue Breakdown

Chart: Revenue Breakdown for Viking Therapeutics. Values in USD billions. In Q2 2026: Revenue 0, Gross Profit 0, Operating Income -0.133.

Revenue Flow

Chart: Revenue Flow for Viking Therapeutics. Q2 2026, values in USD. Revenue 0, Cost of Revenue 0, Gross Profit 0, Net Income -0.128, Operating Income -0.133.

Balance Sheet

Chart: Balance Sheet for Viking Therapeutics. Values in currency. In Q2 2026: Total Assets 0.522, Total Liabilities 0.114, Total Equity 0.408.

Q3 2016-Q2 2026

Cash Flow

Chart: Cash Flow for Viking Therapeutics. Values in currency. In Q2 2026: Operating Cash Flow -0.125, Free Cash Flow -0.125, Capital Expenditures 0.

Q3 2016-Q2 2026

Viking Therapeutics (VKTX) - Compare | Sterling

Revenue Breakdown

Chart: Revenue Breakdown for Viking Therapeutics. Values in USD billions. In Q2 2026: Revenue 0, Gross Profit 0, Operating Income -0.133.

Revenue Flow

Chart: Revenue Flow for Viking Therapeutics. Q2 2026, values in USD. Revenue 0, Cost of Revenue 0, Gross Profit 0, Net Income -0.128, Operating Income -0.133.

Balance Sheet

Chart: Balance Sheet for Viking Therapeutics. Values in currency. In Q2 2026: Total Assets 0.522, Total Liabilities 0.114, Total Equity 0.408.

Q3 2016-Q2 2026

Cash Flow

Chart: Cash Flow for Viking Therapeutics. Values in currency. In Q2 2026: Operating Cash Flow -0.125, Free Cash Flow -0.125, Capital Expenditures 0.

Q3 2016-Q2 2026